Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP881829.RA7FVgXEAWzY0rbwObogJ3HJOpi2ero_C2QFHxAFjrgI8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP881829.RA7FVgXEAWzY0rbwObogJ3HJOpi2ero_C2QFHxAFjrgI8130_assertion type Assertion NP881829.RA7FVgXEAWzY0rbwObogJ3HJOpi2ero_C2QFHxAFjrgI8130_head.
- NP881829.RA7FVgXEAWzY0rbwObogJ3HJOpi2ero_C2QFHxAFjrgI8130_assertion description "[Here, we use untargeted metabolomics combined with a genetic mouse model to determine that the poorly characterized serine hydrolase ?/?-hydrolase domain-containing (ABHD)12, mutations in which cause the human neurodegenerative disorder PHARC (polyneuropathy, hearing loss, ataxia, retinosis pigmentosa, and cataract), is a principal lysophosphatidylserine (LPS) lipase in the mammalian brain.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP881829.RA7FVgXEAWzY0rbwObogJ3HJOpi2ero_C2QFHxAFjrgI8130_provenance.
- NP881829.RA7FVgXEAWzY0rbwObogJ3HJOpi2ero_C2QFHxAFjrgI8130_assertion evidence source_evidence_literature NP881829.RA7FVgXEAWzY0rbwObogJ3HJOpi2ero_C2QFHxAFjrgI8130_provenance.
- NP881829.RA7FVgXEAWzY0rbwObogJ3HJOpi2ero_C2QFHxAFjrgI8130_assertion SIO_000772 23297193 NP881829.RA7FVgXEAWzY0rbwObogJ3HJOpi2ero_C2QFHxAFjrgI8130_provenance.
- NP881829.RA7FVgXEAWzY0rbwObogJ3HJOpi2ero_C2QFHxAFjrgI8130_assertion wasDerivedFrom befree-20150227 NP881829.RA7FVgXEAWzY0rbwObogJ3HJOpi2ero_C2QFHxAFjrgI8130_provenance.
- NP881829.RA7FVgXEAWzY0rbwObogJ3HJOpi2ero_C2QFHxAFjrgI8130_assertion wasGeneratedBy ECO_0000203 NP881829.RA7FVgXEAWzY0rbwObogJ3HJOpi2ero_C2QFHxAFjrgI8130_provenance.